Jan 17, 2020 Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Oct 29, 2019 Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on November 1, 2019
Oct 3, 2019 Aethlon Medical Receives Extension from Nasdaq to Regain Compliance with Continued Listing Requirements
Sep 24, 2019 Aethlon Announces Collaboration to Identify Exosomes Involved in Cancer Progression and Treatment Resistance
